Sanofi, one of the world’s leading pharmaceutical companies, recently announced the discontinuation of the development of tusamitamab ravtansine, a potential...
Potential Availability of Landmark Melanoma Vaccine Estimated within 2 Years Melanoma, the deadliest form of skin cancer, has been a...
OurCrowd Blog: Learn about OurCrowd’s Israel Resilience Fund and its initial 8 investments OurCrowd, a leading global investment platform, recently...
Biotechnology, a field that combines biology and technology, has been making significant advancements in recent years. From breakthroughs in gene...
Title: New Melanoma Vaccine Poised to Revolutionize Cancer Treatment within 2 Years Introduction: In recent years, medical advancements have significantly...
FDA Expands Approval for Merck’s $1B Cancer Drug to Treat Wider Range of Patients The U.S. Food and Drug Administration...
How Antibodies Eliminate Abnormal Proteins in Cancer Cells Cancer is a complex disease that arises from the uncontrolled growth and...
Bristol Myers Squibb, a leading global biopharmaceutical company, recently announced its acquisition of SystImmune for a whopping $800 million. This...
GT Medical Technologies, Inc. to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc. GT Medical Technologies, Inc., a leading innovator...
Title: Promising Results from ORSERDU® Combination Studies Presented at the 2023 San Antonio Breast Cancer Symposium Introduction: The 2023 San...
Title: Promising Results from ORSERDU® (Elacestrant) Combination Studies in ER+, HER2- Metastatic Breast Cancer Patients Introduction: The 2023 San Antonio...
Ultrasound Microbubbles: Revolutionizing Imaging and Personalized Medicine In recent years, ultrasound technology has made significant advancements in the field of...
The role of novel lncRNA Gm33149 in melanoma metastasis and its impact on the miR-5623-3p/Wnt axis through exosomal transfer –...
Xenon’s $345 Million Public Offering, EyePoint Pharmaceuticals’ Successful Trial, and Promising Gene Therapy for Liver Cancer Reduction In recent news,...
A recent study has found that women diagnosed with very early-stage breast cancer may be able to safely omit radiation...
